Cargando…

SUN-254 Angiotensin II Stimulates Microglia Cell Inflammatory Responses

Angiotensin II (AngII) is the principal effector molecule of the renin-angiotensin system (RAS). It’s effects on the cardiovascular and renal system are well-documented. AngII acts mainly via interaction with the AngII type-1 receptor (AT1R). Disordered levels of AngII lead to hypertension and cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Velez, Jean Paul Moliere, Inostroza-Nieves, Dra Yaritza, Romero, Jose R, Arenas, Claudia, Capo, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207668/
http://dx.doi.org/10.1210/jendso/bvaa046.1332
_version_ 1783530659162095616
author Velez, Jean Paul Moliere
Inostroza-Nieves, Dra Yaritza
Romero, Jose R
Arenas, Claudia
Capo, Diego
author_facet Velez, Jean Paul Moliere
Inostroza-Nieves, Dra Yaritza
Romero, Jose R
Arenas, Claudia
Capo, Diego
author_sort Velez, Jean Paul Moliere
collection PubMed
description Angiotensin II (AngII) is the principal effector molecule of the renin-angiotensin system (RAS). It’s effects on the cardiovascular and renal system are well-documented. AngII acts mainly via interaction with the AngII type-1 receptor (AT1R). Disordered levels of AngII lead to hypertension and cardiovascular disease. Increasing evidence suggests that AngII may also play a role in the pathophysiology of neurodegenerative diseases through unclear mechanisms. We investigated AngII, AT1R and AT2R levels in a mouse model of neurodegenerative disease, the experimentally induced autoimmune encephalomyelitis (EAE) mouse. In EAE mice, AngII and AT1R gene expression in brain tissue were significantly increased when compared to control mice (3.2 folds ±1.9, p<0.05, n=5; and 2.6 folds ±1.1, p<0.01, n=5 respectively). In addition, iNOS mRNA expression by qRT-PCR was likewise upregulated in EAE mice compared to control (3.4 ± 1.4 folds, p<0.01, n=5). We then studied the effects of AngII in human microglial cells (HMC3) -resident innate immune cells of the central nervous system (CNS). In HMC3 cells, treatment with AngII up-regulated the expression IL-6 (3.9 folds ± 1.2, p<0.01, n=4) and increased IL-6 concentration by 83% (p<0.05, n=4) by ELISA; effects that were blocked by the AT1R antagonist, Losartan. Also, AngII induced TNF-α production, increasing its concentration by 90% (p<0.05, n=4), an increase that was blocked by Losartan. We also quantified Nitric Oxide (NO) production by using Griess Reagent and reactive oxygen species (ROS) production by the MUSE Oxidative Stress assay. In these cells, NO and ROS production were significantly increased by AngII (p<0.05, n=4) and treatment with Losartan reduced their production (p<0.05, n=4). In addition, AngII treatment induced iNOS overexpression (2.5 folds ±0.8, p<0.05, n=4); results that are consistent with increases in the EAE mice. These data suggest that AngII can activate microglia cell inflammatory responses and as such may contribute to the pathophysiology of CNS inflammation and neurodegenerative diseases.
format Online
Article
Text
id pubmed-7207668
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72076682020-05-13 SUN-254 Angiotensin II Stimulates Microglia Cell Inflammatory Responses Velez, Jean Paul Moliere Inostroza-Nieves, Dra Yaritza Romero, Jose R Arenas, Claudia Capo, Diego J Endocr Soc Neuroendocrinology and Pituitary Angiotensin II (AngII) is the principal effector molecule of the renin-angiotensin system (RAS). It’s effects on the cardiovascular and renal system are well-documented. AngII acts mainly via interaction with the AngII type-1 receptor (AT1R). Disordered levels of AngII lead to hypertension and cardiovascular disease. Increasing evidence suggests that AngII may also play a role in the pathophysiology of neurodegenerative diseases through unclear mechanisms. We investigated AngII, AT1R and AT2R levels in a mouse model of neurodegenerative disease, the experimentally induced autoimmune encephalomyelitis (EAE) mouse. In EAE mice, AngII and AT1R gene expression in brain tissue were significantly increased when compared to control mice (3.2 folds ±1.9, p<0.05, n=5; and 2.6 folds ±1.1, p<0.01, n=5 respectively). In addition, iNOS mRNA expression by qRT-PCR was likewise upregulated in EAE mice compared to control (3.4 ± 1.4 folds, p<0.01, n=5). We then studied the effects of AngII in human microglial cells (HMC3) -resident innate immune cells of the central nervous system (CNS). In HMC3 cells, treatment with AngII up-regulated the expression IL-6 (3.9 folds ± 1.2, p<0.01, n=4) and increased IL-6 concentration by 83% (p<0.05, n=4) by ELISA; effects that were blocked by the AT1R antagonist, Losartan. Also, AngII induced TNF-α production, increasing its concentration by 90% (p<0.05, n=4), an increase that was blocked by Losartan. We also quantified Nitric Oxide (NO) production by using Griess Reagent and reactive oxygen species (ROS) production by the MUSE Oxidative Stress assay. In these cells, NO and ROS production were significantly increased by AngII (p<0.05, n=4) and treatment with Losartan reduced their production (p<0.05, n=4). In addition, AngII treatment induced iNOS overexpression (2.5 folds ±0.8, p<0.05, n=4); results that are consistent with increases in the EAE mice. These data suggest that AngII can activate microglia cell inflammatory responses and as such may contribute to the pathophysiology of CNS inflammation and neurodegenerative diseases. Oxford University Press 2020-05-08 /pmc/articles/PMC7207668/ http://dx.doi.org/10.1210/jendso/bvaa046.1332 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Neuroendocrinology and Pituitary
Velez, Jean Paul Moliere
Inostroza-Nieves, Dra Yaritza
Romero, Jose R
Arenas, Claudia
Capo, Diego
SUN-254 Angiotensin II Stimulates Microglia Cell Inflammatory Responses
title SUN-254 Angiotensin II Stimulates Microglia Cell Inflammatory Responses
title_full SUN-254 Angiotensin II Stimulates Microglia Cell Inflammatory Responses
title_fullStr SUN-254 Angiotensin II Stimulates Microglia Cell Inflammatory Responses
title_full_unstemmed SUN-254 Angiotensin II Stimulates Microglia Cell Inflammatory Responses
title_short SUN-254 Angiotensin II Stimulates Microglia Cell Inflammatory Responses
title_sort sun-254 angiotensin ii stimulates microglia cell inflammatory responses
topic Neuroendocrinology and Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207668/
http://dx.doi.org/10.1210/jendso/bvaa046.1332
work_keys_str_mv AT velezjeanpaulmoliere sun254angiotensiniistimulatesmicrogliacellinflammatoryresponses
AT inostrozanievesdrayaritza sun254angiotensiniistimulatesmicrogliacellinflammatoryresponses
AT romerojoser sun254angiotensiniistimulatesmicrogliacellinflammatoryresponses
AT arenasclaudia sun254angiotensiniistimulatesmicrogliacellinflammatoryresponses
AT capodiego sun254angiotensiniistimulatesmicrogliacellinflammatoryresponses